Epidemiology of STD & Infectious Diseases

STI epidemiology and management have evolved interactively, particularly in developing countries. Technological advances in diagnosis, screening, and treatment; evaluation and widespread implementation of new case-management algorithms; and changes in risk behaviors in response to the AIDS epidemic have all influenced the dynamic typology of STIs. Every year worldwide, there are approximately 357 million new infections of syphilis, chlamydia, gonorrhea, and trichomoniasis. A major recent advance in STI prevention is the early success of a prophylactic, monovalent human papillomavirus (HPV) type 16 vaccine, HPV vaccines may be able to help prevent genital and anal cancers in the foreseeable future.


  • Track 1-1 Syndromic Management
  • Track 2-2 Role of Core Groups
  • Track 3-3 Antibiotic Use
  • Track 4-4 Drug Resistance
  • Track 5-5 Sexual Health Care
  • Track 6-6 Social Risk Markers
  • Track 7-7 Behavioral Risk Factors
  • Track 8-8 Clinical interventions

Related Conference of Infectious Diseases